Please download the dossier by clicking on the dossier button x
×

Mesenchymal stem cells and uses therefor

  • US 9,694,035 B2
  • Filed: 07/17/2014
  • Issued: 07/04/2017
  • Est. Priority Date: 03/22/2004
  • Status: Active Grant
First Claim
Patent Images

1. A method of reducing inflammation in the gastrointestinal tract of a patient in need thereof, comprising the step of intravenously or intraarterially administering to a human suffering from inflammation of the gastrointestinal tract a suspension of cells in an amount effective to reduce the inflammation, wherein the cells are genetically unmodified allogeneic mesenchymal stem cells, wherein the suspension of mesenchymal stem cells is at least 95% homogeneous and wherein the mesenchymal stem cells express CD73 and CD105.

View all claims
  • 5 Assignments
Timeline View
Assignment View
    ×
    ×